title: Renal outcomes in the ONTARGET study.
authors.forename: Raj Mohan Lekshmi
authors.initials: RM
authors.lastname: Narayanan
authors.forename: Lim Su
authors.initials: LS
authors.lastname: Chi
authors.forename: Lim Ling
authors.initials: LL
authors.lastname: Choo
authors.forename: Yeoh Lee
authors.initials: YL
authors.lastname: Ying
authors.forename: Sum Chee
authors.initials: SC
authors.lastname: Fang
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D010352:Patient Dropouts; D016032:Randomized Controlled Trials as Topic; D015983:Selection Bias
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors